Purchase Order VA24817P2467
Award Date 4/6/17
Potential Completion Date 4/14/17
Potential Value $75K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $76,548.40 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Walgreen Co., doing business as Walgreens, for the delivery of LEMTRADA injections. The contract has no set-aside designation and was awarded on July 1, 2018, with a completion date of July 2, 2018. Walgreens is a major federal contractor and grant recipient, leveraging its nationwide network of retail pharmacies to support various federal healthcare initiatives, including COVID-19...
- This is a federal purchase order contract awarded by the Veterans Integrated Service Network 5 (VISN 5), a civilian agency, to Walgreen Co. (Walgreens) for LEMTRADA IV injections. The contract has a ceiling value of $76,548.40 and a firm fixed price pricing type, with an ultimate completion date of April 2, 2018. The contract was not set aside for any specific business type. Walgreens, a major pharmacy health and daily living retailer, has been awarded several federal contracts and grants to...
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Walgreens Specialty Pharmacy, LLC in the amount of $12,580.72. The contract is for the delivery of the medication Jynarque (tolvaptan) to treat autosomal dominant polycystic kidney disease. This contract was awarded to Walgreens Specialty Pharmacy as the prime contractor, with no set-aside designation mentioned. The contract period of performance runs through March 19,...
- This federal contract award, valued at $12,580.72, was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Walgreens Specialty Pharmacy, LLC, a division of the broader Walgreens retail pharmacy chain. The contract is a firm fixed price purchase order for the medication Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. This is one of several similar contracts Walgreens Specialty Pharmacy has received from...
- This federal contract award is for the delivery of the medication Jynarque (tolvaptan) to the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) facilities within the Veterans Integrated Service Network 2 (VISN 2). The $12,580.72 firm fixed price purchase order was awarded to Walgreens Specialty Pharmacy, LLC, a division of the Walgreens retail pharmacy chain, on October 2, 2024. The contract has an ultimate completion date of October 3, 2024 and does not utilize any...
- Walgreens Specialty Pharmacy, LLC was awarded a $11,425.69 firm fixed price purchase order as the prime contractor to supply Jynarque 45MG/15MG tablets to the Department of Veterans Affairs Veterans Health Administration (VHA) Veterans Integrated Service Network 2. Performance will occur at Walgreens' location in Pittsburgh, Pennsylvania. As a specialty pharmacy, Walgreens will fulfill this non-set aside contract to rapidly provide the branded medication to VHA pharmacies in Network 2 in support...
- This federal contract award is for the delivery of LEMTRADA INJECTION VIALS to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract was awarded to Genzyme Corporation, doing business as Sanofi Genzyme, a global healthcare and pharmaceutical company. It is a firm fixed price delivery order under Genzyme's $659 million Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, which allows the VHA to issue task orders for a...
- This is a $103,003.20 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract is for the delivery of various complex and high-value medications, primarily to support the VA's Veterans Integrated Service Network (VISN) healthcare facilities. Key medications provided under this contract include drugs used to treat...
- This is a $40,697.68 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the supply of specialty pharmaceutical products, including medications to treat pulmonary arterial hypertension, neuropathic lysosomal storage disorders, and ophthalmic disorders. The contract has an ultimate completion date of March 14, 2025 and is part of the VA's Veterans...
- This is a firm fixed-price purchase order award from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Accredo Health Group, Inc., a for-profit pharmaceutical distribution company. The $38,493.36 contract is for the delivery of LUMRYZ 9GM/PKT (sodium oxybate), a specialty medication, to support the VHA's integrated healthcare networks. As a prime contractor, Accredo regularly fulfills purchase orders and multi-year contracts with the VA to supply specialty...